Cargando…
Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis
Background: Several studies have revealed the potential use of tocilizumab in treating COVID-19 since no therapy has yet been approved for COVID-19 pneumonia. Tocilizumab may provide clinical benefits for cytokine release syndrome in COVID-19 patients. Methods: We searched for relevant studies in Pu...
Autores principales: | Nugroho, Cahyo Wibisono, Suryantoro, Satriyo Dwi, Yuliasih, Yuliasih, Rosyid, Alfian Nur, Asmarawati, Tri Pudy, Andrianto, Lucky, Setiawan, Herley Windo, Mahdi, Bagus Aulia, Windradi, Choirina, Agustin, Esthiningrum Dewi, Fajar, Jonny Karunia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953915/ https://www.ncbi.nlm.nih.gov/pubmed/33763201 http://dx.doi.org/10.12688/f1000research.45046.1 |
Ejemplares similares
-
Predictive Value of Sequential Organ Failure Assessment, Quick Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation II, and New Early Warning Signs Scores Estimate Mortality of COVID-19 Patients Requiring Intensive Care Unit
por: Asmarawati, Tri Pudy, et al.
Publicado: (2022) -
Hemodynamic, Oxygenation and Lymphocyte Parameters Predict COVID-19 Mortality
por: Windradi, Choirina, et al.
Publicado: (2023) -
The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya
por: Asmarawati, Tri Pudy, et al.
Publicado: (2021) -
Prognosticating 2-Year Survival Rate of Breast Cancer Patients Through Plasma miRNA-21 and Other Associating Factors
por: Romadhon, Pradana Zaky, et al.
Publicado: (2022) -
Case Report: Priapism as The Clinical Presenting Feature of Chronic Myeloid Leukemia: Case Report and 20-Year Literature Review
por: Bintoro, Siprianus Ugroseno Yudho, et al.
Publicado: (2022)